Skip to Main

Search

Results 871 to 880 of 987 for ""

Renowned researcher joining UTSW is among recipients of up to $25 million Cancer Grand Challenges award: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2026/march-cancer-grand-challenges-award.html

Jean-Laurent Casanova, M.D., Ph.D., an internationally recognized expert in the fields of genetics, immunology, and infectious diseases who will be joining UT Southwestern Medical Center on July 1, has been selected along with a global team of researchers to receive a Cancer Grand Challenges award

Kenneth Altshuler, M.D., who led UT Southwestern department of psychiatry for 23 years, dies at 91 : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/altshuler-psychiatry.html

Kenneth Altshuler, M.D., a professor emeritus and longtime chair of psychiatry at UT Southwestern who helped to advance mental health causes in Dallas, died Jan. 6. He was 91.

Patient Notification: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/dec-media-statement.html

UT Southwestern Medical Center is notifying individuals whose data may have been inappropriately disclosed; however, UT Southwestern has received no indication that the information has been used inappropriately.

Patient Notification: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/sept-patient-notification.html

UT Southwestern is notifying patients treated by UT Southwestern physicians of improper disclosure of protected health information.

Swapping alpha cells for beta cells to treat diabetes: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/beta-cells-diabetes.html

Antibodies that convert glucagon-producing cells into insulin-producing ones cure mouse models of the disease

Combo diabetes treatment amplifies effectiveness, improves medication adherence: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/combo-diabetes-treatment.html

A once-daily combination treatment for those with uncontrolled Type 2 diabetes amplifies the treatment’s effects – lowering both weight and the number of hypoglycemic events, and improving quality of life and glucose control ¬– and makes participants more likely to adhere to their medications.

Hibbs honored with Hackerman Award for work on structure and function of receptors in the brain: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/hibbs-hackerman-award.html

UT Southwestern structural biologist and neuroscientist Ryan Hibbs, Ph.D., has received a 2022 Norman Hackerman Award in Chemical Research.

HHMI Investigator/NAS member Dr. Beth Levine<br / >Director of UT Southwestern Center for Autophagy Research: 1960-2020: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/beth-levine.html

Dr. Beth Levine, UT Southwestern Professor of Internal Medicine and Microbiology, Director of the Center for Autophagy Research, and holder of the Charles Cameron Sprague Distinguished Chair in Biomedical Science, died Sunday after a battle with breast cancer.

Stomach issues, history of substance abuse found in teen vaping study: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/teen-vaping-study.html

A study of teens diagnosed with the vaping-linked respiratory disease EVALI revealed that most also had gastrointestinal symptoms and a history of psychosocial factors, including substance abuse.

UT Southwestern investigators report first analysis of pioneering kidney cancer radiation approach in clinical trial: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/kidney-cancer-radiation.html

A new approach using precisely targeted, high-dose radiation to treat invasive kidney cancer proves safe, based on a clinical trial by the UT Southwestern Harold C. Simmons Comprehensive Cancer Center’s kidney cancer program.